Prevention of cardiovascular disease in asymptomatic people

Heart

Volumn 96, Issue 6, 2010, Pages 477-482

  De Backer, Guy ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ARTERIAL WALL THICKNESS; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL PRACTICE; DISEASE SEVERITY; EXERCISE; EXTERNAL VALIDITY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMORAL ARTERY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH CARE SYSTEM; HEALTH EDUCATION; HEALTH PRACTITIONER; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SALT INTAKE; SCREENING TEST; SMOKING CESSATION; TRIACYLGLYCEROL BLOOD LEVEL; WORKLOAD;

ADULT; AGED; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; LIFE STYLE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS;

EID: 77949629085     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2009.169045     Document Type: Review

References (12)

1. British Heart Foundation Statistics Database. Coronary heart disease statistics 2007. 2008 http://www.heartstats.org. ▶ Extensive source of recent statistics on CHD morbidity, mortality and treatmentd - latest edition.
2. Klenk J, Rapp K, Büchele G, et al. Increasing life expectancy in Germany: quantitative contribution from changes in age- and disease specific mortality. Eur J Public Health 2007:17:587-92. ▶ Original and interesting analysis of changes in life expectancy related to age and cause specific mortality.
3. Fourth Joint Task Force of the European Society of Cardiology and other Societies on CVD prevention in clinical practice. European guidelines on CVD prevention in clinical practice. Eur J Cardiovasc Prev Rehab 2007;14(suppl 2):S1-113. ▶ Last update of the Joint European Societies' guidelines on prevention of cardiovascular disease in clinical practice.
4. Rose G. The strategy of preventive medicine Oxford: Oxford University Press, 1992. ▶ A book that will remain a milestone in preventive medicine.
5. Wood D, De Backer G, Faergeman O, et al. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task force of European and other Societies on Coronary prevention. Eur Heart J 1998;19:1434-503.
6. Anderson KM, Wilson PWF, Odell PM, et al. An updated coronary risk profile: a statement for health professionals. Circulation 1991;83:356-62.
7. National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
8. Joint British Society Guidelines 2. Joint British Society guidelines on prevention of CVD in clinical practice. Heart 2005;91 (suppl V):v1-52.
9. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehab 2003;10(suppl 1):S1-78.
10. World Health Organization/International Society of Hypertension Guidelines Sub-committee. 1999 World Health Organization/International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999;17:151-83.
11. European Society of Hypertension, European Society of Cardiology. The task force for the management of arterial hypertension of the ESH and of the ESC 2007 guidelines for the management of arterial hypertension. Eur Heart J 2007;28:1462-536.
12. Lloyd-Jones DM, Leip EP, Larson MG, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006;113:791-8. ▶ Original approach of CVD risk prediction moving from 10 year risk estimation into lifetime risk.